BioCatalyst

Tazemetostat, Tazemetostat, Lenalidomide, Rituximab — catalyst calendar

1 verified catalyst event(s) referencing Tazemetostat, Tazemetostat, Lenalidomide, Rituximab, each linked to its official source. Verified as of 2026-10-14.

Upcoming

DateEventCompanyDrugOfficial source & verification
2027-02-13
in 4mo
ESTIMATED
 READOUT
A Study to Assess the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics o
Phase 3 · Relapsed/Refractory Follicular Lymphoma, Follicular Lymphoma
 Epizyme, Inc. Tazemetostat, Tazemetostat, Lenalidomide ClinicalTrials.gov ↗
✓ Source-checked 2026-10-14
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.